Efficacy of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients with uncommon EGFR 21L861Q mutation#br#
HU Zhang-guo, CAO Shu-hui, ZHONG Hua
上海交通大学学报（医学版） . 2017, (11): 1524 .  DOI: 10.3969/j.issn.1674-8115.2017.11.013